Whole genome characterization, phylogenetic and genome signature analysis of human pandemic H1N1 virus in Thailand, 2009-2012

PLoS One. 2012;7(12):e51275. doi: 10.1371/journal.pone.0051275. Epub 2012 Dec 12.

Abstract

Background: Three waves of human pandemic influenza occurred in Thailand in 2009-2012. The genome signature features and evolution of pH1N1 need to be characterized to elucidate the aspects responsible for the multiple waves of pandemic.

Methodology/findings: Forty whole genome sequences and 584 partial sequences of pH1N1 circulating in Thailand, divided into 1(st), 2(nd) and 3(rd) wave and post-pandemic were characterized and 77 genome signatures were analyzed. Phylogenetic trees of concatenated whole genome and HA gene sequences were constructed calculating substitution rate and d(N)/d(S) of each gene. Phylogenetic analysis showed a distinct pattern of pH1N1 circulation in Thailand, with the first two isolates from May, 2009 belonging to clade 5 while clades 5, 6 and 7 co-circulated during the first wave of pH1N1 pandemic in Thailand. Clade 8 predominated during the second wave and different proportions of the pH1N1 viruses circulating during the third wave and post pandemic period belonged to clades 8, 11.1 and 11.2. The mutation analysis of pH1N1 revealed many adaptive mutations which have become the signature of each clade and may be responsible for the multiple pandemic waves in Thailand, especially with regard to clades 11.1 and 11.2 as evidenced with V731I, G154D of PB1 gene, PA I330V, HA A214T S160G and S202T. The substitution rate of pH1N1 in Thailand ranged from 2.53×10(-3)±0.02 (M2 genes) to 5.27×10(-3)±0.03 per site per year (NA gene).

Conclusions: All results suggested that this virus is still adaptive, maybe to evade the host's immune response and tends to remain in the human host although the d(N)/d(S) were under purifying selection in all 8 genes. Due to the gradual evolution of pH1N1 in Thailand, continuous monitoring is essential for evaluation and surveillance to be prepared for and able to control future influenza activities.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Genome, Viral*
  • Humans
  • Influenza A Virus, H1N1 Subtype / classification
  • Influenza A Virus, H1N1 Subtype / genetics*
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza, Human / epidemiology*
  • Influenza, Human / virology
  • Phylogeny*
  • Thailand / epidemiology

Grants and funding

The authors would like to express their gratitude to the Commission on Higher Education, Ministry of Education, the Center of Excellence in Clinical Virology, Chulalongkorn University, Dutsadi Piphat Scholarship, Chulalongkorn University, CU Centenary Academic Development Project, King Chulalongkorn Memorial Hospital, Graduate School of Biomedical Science, Chulalongkorn University, the RGJ PhD program of the Thailand Research Fund, Thailand Research Fund (DPG5480002), National Research University Project of Thailand, Office of the Higher Education Commission (HR1155A-55), MK Restaurant Company Limited and in part with federal funds from the NIAID, United States National Institutes of Health, Department of Health and Human Services, under Contract no. HHSN266200700007c for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.